Celularity Inc. (NASDAQ: CELU) Stock Information | RedChip

Celularity Inc. (NASDAQ: CELU)


$2.1050
+0.6550 ( +45.17% ) 8.3M

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Market Data


Open


$2.1050

Previous close


$1.4500

Volume


8.3M

Market cap


$46.17M

Day range


$1.5050 - $2.6350

52 week range


$1.3000 - $7.9700

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Aug 23, 2024
nt Quarterly Reports 1 Aug 16, 2024
8-k 8K-related 15 Aug 05, 2024
10-k Annual reports 119 Jul 30, 2024
8-k 8K-related 14 May 24, 2024
8-k 8K-related 74 May 21, 2024
nt Quarterly Reports 1 May 15, 2024
8-k 8K-related 14 Apr 22, 2024
4 Insider transactions 1 Apr 16, 2024
4 Insider transactions 1 Apr 16, 2024

Latest News